Nxera Pharma Co., Ltd.
SOLTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $32,268,000 | $49,065,000 | $66,557,000 | $60,087,000 |
| Short-Term Investments | $3,935,000 | $0 | $0 | $86,000 |
| Receivables | $6,695,000 | $5,064,000 | $2,462,000 | $2,138,000 |
| Inventory | $8,838,000 | $2,903,000 | $32,000 | -$33,000 |
| Other Curr. Assets | $6,119,000 | $8,080,000 | $891,000 | $530,000 |
| Total Curr. Assets | $57,855,000 | $65,112,000 | $69,942,000 | $62,808,000 |
| Property Plant & Equip (Net) | $7,468,000 | $7,900,000 | $3,791,000 | $3,817,000 |
| Goodwill | $25,693,000 | $24,623,000 | $15,306,000 | $15,095,000 |
| Intangibles | $51,911,000 | $52,291,000 | $8,577,000 | $9,120,000 |
| Long-Term Investments | $583,000 | $3,266,000 | $1,737,000 | $5,957,000 |
| Tax Assets | $4,021,000 | $3,964,000 | $806,000 | $86,000 |
| Other NC Assets | $3,967,000 | $42,000 | -$742,000 | $102,000 |
| Total NC Assets | $93,643,000 | $92,086,000 | $29,475,000 | $34,177,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $151,498,000 | $157,198,000 | $99,417,000 | $96,985,000 |
| Liabilities | – | – | – | – |
| Payables | $4,052,000 | $4,244,000 | $1,628,000 | $1,176,000 |
| Short-Term Debt | $6,690,000 | $6,773,000 | -$120,000 | $193,000 |
| Tax Payable | $255,000 | $378,000 | $260,000 | $279,000 |
| Deferred Revenue | $0 | $1,388,000 | $296,000 | $279,000 |
| Other Curr. Liab. | $4,635,000 | $4,402,000 | $2,028,000 | $5,264,000 |
| Total Curr. Liab. | $15,632,000 | $17,185,000 | $4,092,000 | $7,191,000 |
| LT Debt | $61,210,000 | $67,200,000 | $29,558,000 | $29,078,000 |
| Deferred Rev, NC | $0 | $0 | $4,791,000 | $384,000 |
| Deferred Tax Liab, NC | $1,857,000 | $1,490,000 | $2,922,000 | $2,706,000 |
| Other NC Liab. | $4,281,000 | $4,513,000 | $0 | $0 |
| Total NC Liab. | $67,348,000 | $73,203,000 | $37,389,000 | $32,326,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4,375,000 | $4,817,000 | $1,753,000 | $1,831,000 |
| Total Liabilities | $82,980,000 | $90,388,000 | $41,481,000 | $39,517,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $47,172,000 | $46,807,000 | $41,335,000 | $41,036,000 |
| Retained Earnings | -$20,942,000 | -$16,104,000 | -$8,911,000 | -$9,768,000 |
| AOCI | $7,217,000 | $2,060,000 | -$4,012,000 | -$2,900,000 |
| Other Equity | $35,071,000 | $34,047,000 | $29,524,000 | $29,100,000 |
| Total Equity | $68,518,000 | $66,810,000 | $57,936,000 | $57,468,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $151,498,000 | $157,198,000 | $99,417,000 | $96,985,000 |
| Net Debt | $35,632,000 | $24,908,000 | -$37,119,000 | -$30,816,000 |